Predict your next investment

Corporation
starfishmedical.com

See what CB Insights has to offer

Partners & Customers

10

About StarFish Medical

StarFish Medical is a full service Medical Device Design company with product design, development, and manufacturing services. The firm uses Pathfinder, a process to reduce wasted effort and increase success for medical device product definition, technical engineering, and product development.

StarFish Medical Headquarter Location

455 Boleskine Rd

Victoria, British Columbia, V8Z 1E7,

Canada

250-388-3537

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest StarFish Medical News

SpinaFX and StarFish Medical Enter into a Strategic Commercialization Contract Manufacturing Agreement.

Oct 26, 2021

News provided by Share this article Share this article TORONTO, Oct. 26, 2021 /PRNewswire/ - Minimally invasive image-guided therapy start-up, SpinaFX Medical Inc. (SpinaFX) is pleased to announce the signing of a commercialization contract manufacturing agreement with StarFish Product Engineering Inc. ("StarFish Medical"), Canada's largest medical device design, development, and manufacturing services organization. "SpinaFX is very pleased to welcome StarFish to the SpinaFX team," commented John Soloninka, SpinaFX's Chief Operating Officer. "We ran a rigorous process comparing four of the top, highly-recommended medical device design, commercialization and contract manufacturing organizations from across the US and Canada. StarFish Medical's deep skills and experience, facilities, customer reviews, and willingness to intimately customize and integrate their services with our operations, won the day. The strategic alignment between the companies is excellent!" StarFish Medical is Canada's leading medical device design, development, commercialization and contract manufacturing company with ISO 13485 certified engineering and finished manufacturing services. StarFish has partnered with many successful medical device companies to create  new innovative technologies  across several medical specialties. Scott Philips, CEO or StarFish commented:  "We measure our success through the value we help our clients generate for patients, providers, payers and their shareholders. We select clients that we believe will contribute to our "100x100" objective: 100 clients with over $100M in market capitalization. SpinaFX's minimally-invasive image-guided procedure promises to reduce the time, cost and complexity of spine surgery for patients with low back pain, one of the largest and most costly cohorts of patients worldwide. This is an extremely important goal, and StarFish is committed to helping SpinaFX travel as far and efficiently on their trajectory as possible." "I was very impressed with the quality of responses we received from all competing vendors during our selection process," commented Jeff Cambra, SpinaFX's Chief Executive Officer. "With StarFish, we not only see deep skills, and experience in design, quality, regulatory, and manufacturing optimization, but also their strategic business orientation...ensuring that our product lifecycle jointly optimizes clinical, business, financing and shareholder outcomes. With much of the manufacturing to occur in StarFish's north-west Toronto facility, our organizations will be able to work very closely together. We are excited to transfer manufacturing to StarfFish, and to aggressively pursue our rollout into Canada, EU, FDA and beyond." About the SpinaFX Medical   Headquartered in Ontario, Canada, SpinaFX is a medical device company bringing innovative, minimally invasive image-guided treatments to patients with back pain due to herniated discs. Our patented technology provides surgeons an earlier alternative to conventional surgery, using a minimally invasive technique to deliver a controlled Oxygen formulation to the affected disc, safely reducing the herniation and inflammation causing pain. SpinaFX's Triojection™ product was previously CE Marked under MDD and is undergoing re-certification under MDR. Triojection is not yet approved for sale in the North America, the UK or the EU. About StarFish Medical StarFish Medical provides award-winning design, development, commercialization, and flexible manufacturing outsourcing services —100% dedicated to the medical device and life science marketplace. StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including: Digital Health, Cardiovascular, Neurology, Urology, Gastroenterology, Otology, Ophthalmology, and In-Vitro Diagnostics. StarFish Medical's technical expertise includes electronics, mechanical, software/firmware systems engineering, in addition to industrial design and human factors. Regulatory Affairs (RA) and Quality Assurance (QA) consultants at StarFish Medical provide regulatory assistance for FDA, CE Mark and Health Canada submissions. Services include QA support for setting up QMS for start-up companies with implementation at the client's site, and assisting with ISO 13485 certification audits. Forward looking Statement This news release contains predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance, referred to herein as "forward-looking statements", which are made as of the date of this news release or as of the effective date of information described in this release, as applicable. The forward-looking statements address such anticipated events or occurrences which may include economic factors, industry trends, market demand, and corporate performance and profitability. Forward-looking statements are often identified through words or expressions including "expects", "anticipates", "plans", "projects", "estimates", "envisages", "assumes", "intends", "strategy", "goals", "objectives" or variations thereof or stating that certain actions, events or results "may", "can", "could", "would", "might" or "will" be taken, occur or be achieved, or the negative of any of these terms and similar expressions). All forward-looking statements are based on current beliefs as well as various assumptions made by, and information currently available to SpinaFX's management team. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that estimates, forecasts, projections, and other forward-looking statements will not be achieved or that assumptions do not reflect future experience. We caution any person reviewing this news release not to place undue reliance on these forward-looking statements as a number of important factors could cause the actual outcomes to differ materially from the beliefs, plans, objectives, expectations, anticipations, estimates assumptions and intentions expressed in such forward-looking statements. Neither SpinaFX nor its representatives undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by SpinaFX or its representatives or on behalf of either of them, except as may be required by law. SOURCE Spinafx medical inc

StarFish Medical Acquisitions

1 Acquisition

StarFish Medical acquired 1 company. Their latest acquisition was Kangaroo Group on March 28, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/28/2017

$99M

Merger

1

Date

3/28/2017

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Merger

Sources

1

StarFish Medical Partners & Customers

10 Partners and customers

StarFish Medical has 10 strategic partners and customers. StarFish Medical recently partnered with Axolotl Biosciences on July 7, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

7/8/2022

Partner

Canada

1

7/22/2021

Vendor

Canada

1

7/22/2021

Vendor

Canada

Relay Announces Engagement with Canadian MedTech Leader, StarFish Medical, to provide Cybeats Integrated Security Platform for Connected Medical Devices

StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including : Digital Health , Cardiovascular , Neurology , Urology , Gastroenterology , Otology , Ophthalmology , and In Vitro Diagnostics .

5

5/20/2020

Vendor

Canada

Subscribe to see more

Subscribe to see more

10

5/18/2020

Client

Canada

Subscribe to see more

Subscribe to see more

10

Date

7/8/2022

7/22/2021

7/22/2021

5/20/2020

5/18/2020

Type

Partner

Vendor

Vendor

Vendor

Client

Business Partner

Country

Canada

Canada

Canada

Canada

Canada

News Snippet

Relay Announces Engagement with Canadian MedTech Leader, StarFish Medical, to provide Cybeats Integrated Security Platform for Connected Medical Devices

StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including : Digital Health , Cardiovascular , Neurology , Urology , Gastroenterology , Otology , Ophthalmology , and In Vitro Diagnostics .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

5

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.